No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Bove, Riley ^a,b   Musallam, Alexander ^a   Healy, Brian C ^a,b,c   Houtchens, Maria ^a,b   Glanz, Bonnie I ^a   Khoury, Samia ^a,b   Guttmann, Charles R ^a,b   De Jager, Philip L ^a,b   Chitnis, Tanuja ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Demyelinating disease; Disease progression; Gender; Menopause; MRI; Multiple sclerosis; Natural history studies

Indexed keywords

ADULT; ARTICLE; BRAIN; BRAIN ATROPHY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FATIGUE IMPACT SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL CAPACITY; PROSPECTIVE STUDY; RELAPSE; SCORING SYSTEM; SEX DIFFERENCE; SHORT FORM 36;

ADULT; AGE FACTORS; AGING; BRAIN; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT (HEALTH CARE); SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS;

EID: 84879823878     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-73     Document Type: Article

References (35)

1. Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, Ebers GC. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006, 5(11):932-936. 10.1016/S1474-4422(06)70581-6, 17052660.
2. Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol 2008, 7(3):268-277. 10.1016/S1474-4422(08)70042-5, 18275928.
3. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis Part II: Noninfectious factors. Ann Neurol 2007, 61(6):504-513. 10.1002/ana.21141, 17492755.
4. Mowry EM, Pesic M, Grimes B, Deen S, Bacchetti P, Waubant E. Demyelinating events in early multiple sclerosis have inherent severity and recovery. Neurology 2009, 72(7):602-608. 10.1212/01.wnl.0000342458.39625.91, 2677540, 19221292.
5. Damasceno A, Von Glehn F, Brandao CO, Damasceno BP, Cendes F. Prognostic indicators for long-term disability in multiple sclerosis patients. J Neurol Sci 2013, 324(1-2):29-33. 10.1016/j.jns.2012.09.020, 23073568.
6. Schoonheim MM, Popescu V, Rueda Lopes FC, Wiebenga OT, Vrenken H, Douw L, Polman CH, Geurts JJ, Barkhof F. Subcortical atrophy and cognition: Sex effects in multiple sclerosis. Neurology 2012, 79(17):1754-1761. 10.1212/WNL.0b013e3182703f46, 23019265.
7. Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain 2006, 129(Pt 3):595-605.
8. Koch M, Kingwell E, Rieckmann P, Tremlett H. The natural history of secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2010, 81(9):1039-1043. 10.1136/jnnp.2010.208173, 20639385.
9. Bove R, Healy B, Augusting A, Musallam T, Gholipour T, Chitnis T. Effect of Gender on Late-Onset Multiple Sclerosis. Multiple Sclerosis Journal 2012, In press.
10. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012, 307(5):491-497. 10.1001/jama.2012.39, 22253363.
11. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, De Villiers TJ. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 2012, 97(4):1159-1168. 10.1210/jc.2011-3362, 3319184, 22344196.
12. Kato I, Toniolo P, Akhmedkhanov A, Koenig KL, Shore R, Zeleniuch-Jacquotte A. Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol 1998, 51(12):1271-1276. 10.1016/S0895-4356(98)00119-X, 10086819.
13. Jacobsen BK, Heuch I, Kvale G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol 2003, 157(10):923-929. 10.1093/aje/kwg066, 12746245.
14. Kurtzke J. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452. 10.1212/WNL.33.11.1444, 6685237.
15. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996, 46(4):907-911. 10.1212/WNL.46.4.907, 8780061.
16. Wei X, Warfield SK, Zou KH, Wu Y, Li X, Guimond A, Mugler JP, Benson RR, Wolfson L, Weiner HL, et al. Quantitative analysis of MRI signal abnormalities of brain white matter with high reproducibility and accuracy. J mag reson Imaging : JMRI 2002, 15(2):203-209.
17. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:1385-1401.
18. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 1994, 21(1):9-14.
19. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Medical care 1992, 30(6):473-483. 10.1097/00005650-199206000-00002, 1593914.
20. Fisher JS, Ritvo PG, Miller DM, Andrews H, Paty DW, LaRocca NG. Multiple sclerosis quality of life inventory: a user's manual 1997, New York: National Multiple Sclerosis Society.
21. Spence RD, Hamby ME, Umeda E, Itoh N, Du S, Wisdom AJ, Cao Y, Bondar G, Lam J, Ao Y, et al. Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci USA 2011, 108(21):8867-8872. 10.1073/pnas.1103833108, 3102368, 21555578.
22. Gold SM, Voskuhl RR. Estrogen and testosterone therapies in multiple sclerosis. Prog Brain Res 2009, 175:239-251. 2724009, 19660660.
23. Voskuhl RR, Palaszynski K. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 2001, 7(3):258-270.
24. Kis B, Rumberg B, Berlit P. Clinical characteristics of patients with late-onset multiple sclerosis. J Neurol 2008, 255(5):697-702. 10.1007/s00415-008-0778-x, 18283394.
25. Tremlett H, Devonshire V. Is late-onset multiple sclerosis associated with a worse outcome?. Neurology 2006, 67(6):954-959. 10.1212/01.wnl.0000237475.01655.9d, 17000960.
26. Sammaritano LR. Menopause in patients with autoimmune diseases. Autoimmun Rev 2012, 11(6-7):A430-A436.
27. Harden CL, Herzog AG, Nikolov BG, Koppel BS, Christos PJ, Fowler K, Labar DR, Hauser WA. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study. Epilepsia 2006, 47(9):1447-1451. 10.1111/j.1528-1167.2006.00507.x, 16981859.
28. Holmqvist P, Wallberg M, Hammar M, Landtblom AM, Brynhildsen J. Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas 2006, 54(2):149-153. 10.1016/j.maturitas.2005.10.003, 16293376.
29. Smith R, Studd JW. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J R Soc Med 1992, 85(10):612-613. 1293688, 1433038.
30. Wundes A, Amtmann D, Brown T, Christian S. Menopause in women with multiple sclerosis. Int J MS Care 2011, 13(Supplement 3):47.
31. Mitchell AJ, Benito-Leon J, Gonzalez JM, Rivera-Navarro J. Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing. Lancet Neurol 2005, 4(9):556-566. 10.1016/S1474-4422(05)70166-6, 16109362.
32. Nortvedt MW, Riise T. The use of quality of life measures in multiple sclerosis research. Mult Scler 2003, 9(1):63-72. 10.1191/1352458503ms871oa, 12617271.
33. Bove RM. Autoimmune diseases and reproductive aging. Clin Immunol 2013, S1521-6616(13):00045-4.
34. El-Etr M, Ghoumari A, Sitruk-Ware R, Schumacher M. Hormonal influences in multiple sclerosis: new therapeutic benefits for steroids. Maturitas 2011, 68(1):47-51. 10.1016/j.maturitas.2010.09.014, 21035281.
35. Taylor HS, Manson JE. Update in hormone therapy use in menopause. J Clin Endocrinol Metab 2011, 96(2):255-264. 10.1210/jc.2010-0536, 21296989.